Murine RNase Inhibitor (40 U/μL)
Research
Online Inquiry

Murine RNase Inhibitor (40 U/μL)

Cat.No: IVDRM-0249 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Murine RNase Inhibitor (40 U/μL)
Catalog No. IVDRM-0249
Description Murine RNase Inhibitor is a recombinant ribonuclease inhibitor expressed in soluble form in E. coli. It inactivates RNases by forming a tight non-covalent complex with the enzyme, and broadly inhibits RNase A, RNase B and RNase C. Compared with the human placental inhibitor, it lacks the two oxidation-sensitive cysteine residues of the human protein, providing higher resistance to oxidation and making it better suited to DTT-sensitive applications such as qPCR. It has been verified by RT-PCR and RT-qPCR to be compatible with a wide range of reverse transcriptases and DNA polymerases, and is ideal for first-strand cDNA synthesis, polysome isolation, in vitro transcription and in vitro cell-free translation systems.
Intended Use Supplied as a raw material for molecular diagnostic and life-science reagent manufacturing.
Typical applications:
First-strand cDNA synthesis
Polysome isolation
In vitro transcription
In vitro cell-free translation systems
RNA protection in RT-PCR and RT-qPCR workflows
Principle / Technology The inhibitor binds RNase non-covalently to form a stable complex, resulting in specific and reversible inactivation of the RNase.
Performance Range / Specifications Broad-spectrum RNase inhibition: inhibits RNase A, RNase B and RNase C
Wide reaction compatibility: active from pH 5.0 to 9.0 and from 25 °C to 60 °C; suitable for use with thermostable reverse transcriptases at 55-60 °C
No effect on the activity of SP6, T7 or T3 RNA polymerases, AMV or M-MLV reverse transcriptases, or Taq DNA polymerase
Large-scale production: single-batch capacity of up to 2 billion units ensures lot uniformity, stability and reliable supply
Specificity Inhibits RNase A, RNase B and RNase C. Does not inhibit or interfere with SP6, T7 or T3 RNA polymerases, AMV or M-MLV reverse transcriptases, or Taq DNA polymerase.
Reaction Conditions / Protocol Active over pH 5.0-9.0 and 25-60 °C; compatible with thermostable reverse transcriptases operating at 55-60 °C.
Components / Formulation Storage buffer: 20 mM HEPES-KOH, 150 mM KCl, 8 mM DTT, 0.5% NP-40, 0.5% Tween-20, 50% glycerol, pH 7.5 ± 0.2 at 25 °C.
Storage Conditions Store at -25 °C to -15 °C.
Shelf Life 2 years when stored at -25 °C to -15 °C.
Package Specifications 2 KU
10 KU
20 KU
100 KU
1,000 KU
20,000 KU
Product Form Liquid (supplied in storage buffer containing 50% glycerol)
Quality Control Free of exonuclease contamination: 200 U of enzyme incubated with 0.5 μg λDNA-HindIII digest in a 20 uL reaction at 37 °C for 4 hours shows no degradation.
Free of nicking endonuclease contamination: 200 U of enzyme incubated with 0.5 μg plasmid DNA in a 20 uL reaction at 37 °C for 4 hours shows no nicking activity.
Free of RNase contamination: 200 U of enzyme incubated with 0.5 μg 293T total RNA in a 20 uL reaction at 37 °C for 4 hours shows no change in RNA banding by agarose gel electrophoresis.
Each lot is tested against these specifications (data shown for three independent lots).
Concentration 40 U/uL
Source / Origin Recombinant murine RNase inhibitor gene expressed in soluble form in E. coli and purified.
pH Range / Optimal pH Active over pH 5.0-9.0
Expiration Date / Stability Stable for 2 years at -25 °C to -15 °C.
Regulatory / Compliance Manufactured under a certified quality management system with quality control testing performed against defined quality standards.
Compatibility Compatible with a broad range of reverse transcriptases and DNA polymerases, as verified by RT-PCR and RT-qPCR. Does not affect SP6, T7 or T3 RNA polymerases, AMV or M-MLV reverse transcriptases, or Taq DNA polymerase.
Recommended Buffer System Supplied in 20 mM HEPES-KOH, 150 mM KCl, 8 mM DTT, 0.5% NP-40, 0.5% Tween-20, 50% glycerol, pH 7.5 ± 0.2 at 25 °C.
Application Notes / Precautions Lacks the two oxidation-sensitive cysteines present in the human placental inhibitor, providing higher antioxidant activity; well suited to high-DTT-sensitive applications such as qPCR.
Batch-to-Batch Consistency Mature protein expression and purification platform with quality control testing against defined standards ensures batch-to-batch consistency; single-batch production capacity of up to 2 billion units supports lot uniformity.

For research use only, not for clinical use.

0
0

There is no product in your cart.